Campiani G - Search Results

1

Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.

Gemma S, Camodeca C, Sanna Coccone S, Joshi BP, Bernetti M, Moretti V, Brogi S, Bonache de Marcos MC, Savini L, Taramelli D, Basilico N, Parapini S, Rottmann M, Brun R, Lamponi S, Caccia S, Guiso G, Summers RL, Martin RE, Saponara S, Gorelli B, Novellino E, Campiani G, Butini S. Gemma S, et al. Among authors: campiani g. J Med Chem. 2012 Aug 9;55(15):6948-67. doi: 10.1021/jm300802s. Epub 2012 Jul 27. J Med Chem. 2012. PMID: 22783984

2

Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.

Campiani G, Garofalo A, Fiorini I, Botta M, Nacci V, Tafi A, Chiarini A, Budriesi R, Bruni G, Romeo MR. Campiani G, et al. J Med Chem. 1995 Oct 27;38(22):4393-410. doi: 10.1021/jm00022a005. J Med Chem. 1995. PMID: 7473567

3

A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines toward mitochondrial benzodiazepine receptors.

Dalpiaz A, Bertolasi V, Borea PA, Nacci V, Fiorini I, Campiani G, Mennini T, Manzoni C, Novellino E, Greco G. Dalpiaz A, et al. Among authors: campiani g. J Med Chem. 1995 Nov 10;38(23):4730-8. doi: 10.1021/jm00023a013. J Med Chem. 1995. PMID: 7473601

4

A comparative molecular field analysis model for 6-arylpyrrolo[2,1-d] [1,5]benzothiazepines binding selectively to the mitochondrial benzodiazepine receptor.

Greco G, Novellino E, Fiorini I, Nacci V, Campiani G, Ciani SM, Garofalo A, Bernasconi P, Mennini T. Greco G, et al. Among authors: campiani g. J Med Chem. 1994 Nov 25;37(24):4100-8. doi: 10.1021/jm00050a007. J Med Chem. 1994. PMID: 7990110

5

Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studies.

Fiorini I, Nacci V, Ciani SM, Garofalo A, Campiani G, Savini L, Novellino E, Greco G, Bernasconi P, Mennini T. Fiorini I, et al. Among authors: campiani g. J Med Chem. 1994 May 13;37(10):1427-38. doi: 10.1021/jm00036a007. J Med Chem. 1994. PMID: 8182701

6

Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.

Campiani G, Nacci V, Fiorini I, De Filippis MP, Garofalo A, Greco G, Novellino E, Altamura S, Di Renzo L. Campiani G, et al. J Med Chem. 1996 Jul 5;39(14):2672-80. doi: 10.1021/jm950702c. J Med Chem. 1996. PMID: 8709096

7

Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.

Campiani G, Fiorini I, De Filippis MP, Ciani SM, Garofalo A, Nacci V, Giorgi G, Sega A, Botta M, Chiarini A, Budriesi R, Bruni G, Romeo MR, Manzoni C, Mennini T. Campiani G, et al. J Med Chem. 1996 Jul 19;39(15):2922-38. doi: 10.1021/jm960162z. J Med Chem. 1996. PMID: 8709127

8

Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands.

Campiani G, Nacci V, Fiorini I, De Filippis MP, Garofalo A, Ciani SM, Greco G, Novellino E, Williams DC, Zisterer DM, Woods MJ, Mihai C, Manzoni C, Mennini T. Campiani G, et al. J Med Chem. 1996 Aug 30;39(18):3435-50. doi: 10.1021/jm960251b. J Med Chem. 1996. PMID: 8784441

9

Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model.

Corelli F, Manetti F, Tafi A, Campiani G, Nacci V, Botta M. Corelli F, et al. Among authors: campiani g. J Med Chem. 1997 Jan 3;40(1):125-31. doi: 10.1021/jm9605647. J Med Chem. 1997. PMID: 9016337

10

Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure.

Campiani G, Cappelli A, Nacci V, Anzini M, Vomero S, Hamon M, Cagnotto A, Fracasso C, Uboldi C, Caccia S, Consolo S, Mennini T. Campiani G, et al. J Med Chem. 1997 Oct 24;40(22):3670-8. doi: 10.1021/jm970376w. J Med Chem. 1997. PMID: 9357534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters